Robotic Exosuit for Stroke Rehabilitation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new robotic exosuit designed to help people walk better after a stroke. The goal is to determine if the exosuit can improve walking speed and quality by assisting with leg movement. Researchers aim to understand if individuals with varying muscle control patterns respond differently to the exosuit. Participants should be stroke survivors with noticeable walking difficulties, able to walk without support, and fit within certain height and weight limits. As an Early Phase 1 trial, this research focuses on understanding how the exosuit functions in people, offering participants the opportunity to be among the first to experience this innovative technology.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this robotic exosuit is safe for stroke rehabilitation?
Research has shown that robotic exosuits, used to assist walking after a stroke, are generally safe. Studies have found that these devices can enhance walking speed and strength for stroke survivors. For instance, one study discovered that using an exosuit can reduce the effort needed for walking, making it easier and less tiring.
Although exosuits have been around for a while, this study is in its early stages. Researchers are still collecting initial safety information specific to this trial. However, past research indicates that these devices are usually well-tolerated, with no major safety issues reported. They are designed to aid movement without causing harm or discomfort.
In summary, for those considering joining a trial for robotic exosuit-assisted rehabilitation, existing research supports their safety in improving walking for stroke survivors.12345Why are researchers excited about this trial?
Researchers are excited about the Robotic Exosuit for stroke rehabilitation because it offers a new way to assist patients during gait training. Unlike traditional physical therapy, which relies on manual support and exercises, this exosuit provides targeted, robotic assistance to the ankle, enhancing walking patterns and potentially speeding up recovery. The exosuit's ability to adapt to the wearer's movements in real-time makes it a promising tool for more personalized and efficient stroke rehabilitation.
What evidence suggests that the robotic exosuit is effective for stroke rehabilitation?
Research has shown that robotic exosuits can greatly help stroke patients walk better. Studies indicate these devices increase walking speed and balance, strengthen the legs, and improve overall quality of life. In this trial, participants will walk without robotic ankle assistance as a comparator. Robotic exosuits ease walking by reducing muscle strain, allowing stroke survivors to move more comfortably. Early results suggest these devices help correct unusual walking patterns, enabling users to walk more normally. These findings highlight the potential of robotic exosuits in stroke recovery.12346
Are You a Good Fit for This Trial?
This trial is for adults who had a stroke at least six months ago and now have trouble walking. They should be able to walk, even if it's not perfect, and they're looking into how robotic ankle support can help improve their gait.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete treadmill and overground walking assessments without robotic exosuit assistance
Treatment
Participants perform walking trials with robotic exosuit assistance at different assistance onset timings
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Robotic Exosuit-assisted Gait Rehabilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University Charles River Campus
Lead Sponsor